ODDB.org: Open Drug Database

Rizatrip-Mepha oro 10 mg, Schmelztabletten - 12 Tablette(n)

Swissmedic Key	65035008	Registration Holder	Mepha Pharma AG
Name	Rizatrip-Mepha oro 10 mg, Schmelztabletten	Date of registration	29.09.2014
		Introduction of Sequence	29.09.2014
ATC-Classification	Rizatriptan (N02CC04)	Revision date
WHO	WHO-DDD	Valid until	28.09.2019
Index Therapeuticus (BSV)		Show package size	12 Tablette(n)
Index Therapeuticus (Swissmedic)	02.05.10.	Description
Swissmedic categorie.	B
SL Eintrag	No	Indication
Information for professionals		Consumer information
Ex-factory-Price	PR
Deductible	k.A.	Consumer price	PR
Feedback	FB
GTIN	7680650350088	Medication Code	Synthetika human
Pharmacode		Disponibility

Composition

rizatriptanum 10 mg ut rizatriptani benzoas, aspartamum, aromatica, excipiens pro compresso.

Packungsbestandteile

Galenic Form

Melting tablets

Excipiens

Active Agent	Dose
Rizatriptan	10 mg correspond Rizatriptan Benzoate

Inactive agents
Aromatica
Aspartame

Source

Data was imported : 07.07.2015 Swissmedic Registration : 65035 Sequence : 02 Product name : Rizatrip-Mepha oro 10 mg, Schmelztabletten Registration owner: : Mepha Pharma AG Product group : Index Therapeuticus (BSV) : 02.05.1. Medication Code : Synthetika human Date of registration : 29.09.2014 Valid until : 28.09.2019 Package number : 008 Show package size : 12 Commercial Form/Unit : Tablette(n) Swissmedic categorie. : B Active Agents : rizatriptanum Composition : rizatriptanum 10 mg ut rizatriptani benzoas, aspartamum, aromatica, excipiens pro compresso.

2024	©ywesee GmbH